STAMBP and diabetic retinopathy: Diabetic mice and rats treated with α-MSH or melanocortin receptor agonists have suppressed pathology and cytokines of diabetic retinopathy, including the retention of viable photoreceptors and ganglion cells [20,21,22,23,24].